期刊文献+

miR-142-3p在结直肠癌中的表达及其临床意义 被引量:3

Expression of miR-142-3p in human colorectal cancer and its clinical significance
下载PDF
导出
摘要 目的探讨结直肠癌组织中miR-142-3p的表达及其与临床病理特征的关系。方法分别提取42例结直肠癌患者癌组织及癌旁组织标本中的总RNA,以RT-PCR及荧光定量PCR技术测定miR-142-3p的表达量,并分析miR-142-3p的表达与肿瘤的侵袭、转移等临床病理特征及预后的关系。结果结直肠癌组织中miR-142-3p的表达低于对应的癌旁组织[-2.652(-0.469^-4.420)vs-1.046(-0.488^-2.589)],癌旁组织中miR-142-3p的表达是癌组织中的3.258倍,两者具有统计学差异(P<0.05),miR-142-3p的低表达与结直肠癌淋巴结转移、临床分期有关(均P<0.05);而与患者的年龄、性别、肿瘤大小、远处转移、肿瘤位置、肿瘤浸润深度、分化程度无关(均P>0.05)。结论 miR-142-3p在结直肠癌的发生、发展中可能起着抑癌基因的作用,有望成为结直肠癌诊断与治疗的另一新指标。 Objective To investigate the expression of miR-142-3p in colorectal cancer and its clinicopathological significance. Methods Surgical specimens of cancer tissues and adjacent normal mucosa were obtained from 42 patients with colorectal cancer. Total RNA of cancer tissues and adjacent normal mucosa were extracted, and the relative expression levels of miR-142-3p were detected by quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR). The correlation of miR-142-3p with tumor invasion, metastasis and other clinicalpathologic parameters was analyzed. Results The retarive expression levels of miR-142-3p were significantly lower in colorectal cancer tissues than those in normal mucosa [-2.652 (-0.469--4.420) vs -1.046 (-0.488--2.589), P〈0.05]. The expression of miR-142-3p was negative correlated with the lymph node metastases and clinical stage (P〈0.05); there was no significant correlation of miR-142-3p with age, gender, tumor size, site, distant metastases, depth of tumor invasion, differentiation degree (P 〉0.05). Conclusion The expression of miR-142-3p may play a tumor suppressor role in the development of colorectal cancer, it might be used as an indicator for diagnosis and treatment of colorectal cancer.
出处 《浙江医学》 CAS 2013年第17期1565-1567,1598,共4页 Zhejiang Medical Journal
基金 浙江省自然科学基金资助项目(Y2100917) 瑞安市科技局资助项目(201102039)
关键词 结直肠癌 miR-142-3p荧光定量PCR抑癌基因 Colorectal cancer MiR-142-3p Quantitative real-time PCR Cancer suppressor gene
  • 相关文献

参考文献18

  • 1Odgaard A O,Koh W P,Yuan J M.Combined lifestyle factors and risk of incident colorectal cancer in a chinese population[J].Can- cer Prey Res(Phila), 2013, 6(4):360-367.
  • 2Langan R C,Mullinax J E,Raiji M T, et aI.Colorectal cancer biomar - kers and the potential role of cancer stem cells[J].J Cancer, 2013, 4(3): 241-250.
  • 3Backman V,Roy H K.Advances in biophotonics detection of field carcinogenesis for colon cancer risk stratification[J].J Cancer, 2013, 4(3):251-261.
  • 4Krek A,Gr u n D,Poy M N ,et aI,Combinatorial microRNA target predictions[J].Nat Genet,2005,37(5):495-500.
  • 5Mirnezami A H,Pickard K,Zhang L, et aI.MicroRNAs: Key players in carcinogenesis and novel therapeutic targets[J].Eur J Surg Oncol, 2009, 35(4):339-347.
  • 6He L,Thomason J M,Hemann M T,et aI.A microRNA polycistron as a potential human oncogene [J ]. Nature, 2005,435 ( 7043): 828-833.
  • 7Li J M,Zhao R H,Li S T,et aI.Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer[J].Sandi Med J, 2012, 33(1):24-29.
  • 8Nugent M,Miller N,Kerin M J.MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers[J].Eur J Surg Oncol, 2011, 37(8): 649-654.
  • 9Chen X,Guo X,Zhang H,et aI.Role of miR-143 targeting KRAS in colorectal tumorigenesis[J].Oncogene,2009,28(10): 1385-1392.
  • 10Luo H,Zou J,Dong Z,et al.Up-regulated miR-17 promotes cell proliferation, tumour growth and cellcycle progression by tar- geting the RND3 tumour suppressor gene in colorectal carci- noma[J].Bioohem J, 2012, 442(2):311-321.

二级参考文献22

  • 1Cimino G, Cenfra N, Elia L, et al. The therapeutic response and clinical outcome of adults with ALL1 (MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. Haematologica, 2010 ; 95 (5) : 837 - 840.
  • 2Li Q, Frestedt JL, Kersey JH. AF4 encodes a ubiquitous protein that in both native and mll-af4 fusion types localizes to subnuclear compartments. Blood, 1998; 92(10): 3841 -3847.
  • 3Liu H, Cheng EH, Hsieh JJ. MLL fusions: pathways to leukemia. Cancer Biol Ther, 2009 ; 8 ( 13 ) : 1204 - 1211.
  • 4Maitta RW, Cannizzaro LA, Ramesh KH. Association of MLL amplification with poor outcome in acute myeloid leukemia. Cancer Genet Cytogenet, 2009 ; 192 ( 1 ) : 40 - 43.
  • 5Yamaguchi H, Hanawa H, Uchida N, et al. Multistep patho- genesis of leukemia via the mll-af4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression. Exp Hematol, 2009 ; 37 (6) : 701 - 714.
  • 6Ju X, Li D, Shi Q, et al. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia. Pediatr Hematol Oncol, 2009 ; 26 ( 1 ) : I - 10.
  • 7Liu Q, Fu H, Sun F, et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res, 2008; 36(16) : 5391 -5404.
  • 8Stacker SA, Achen MG, Jussila L, et al. Lymphangio- genesis and cancer metastasis[J]. Nat Rev Cancer, 2002, 2(8): 573-583.
  • 9Bartel DP. MicroRNAs: genomics, biogenesis, mecha- nism, and function[J]. Cell, 2004, 116(2): 281-297.
  • 10Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer[J]. Nat Rev Cancer, 2006, 6(4): 259-269.

共引文献5

同被引文献14

  • 1Hansen T F, Sφrensen F B, Lindebjerg J, eta of microRNA-126 in relation to first capecitabine and oxaliplatin in patients with cancer[J]. BMC cancer ,2012, 12(1):83. The predictive value ine treatment with metastatic colorectal.
  • 2Gulhati P, Bowen K A, Liu J, et al. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Racl signaling pathways[J]. Cancer research, 2011, 71(9):3246- 3256.
  • 3Shang J, Fu Y, Wang Y, et al. MicroRNA-23a Antisense Enhances 5-Fluorouracil Chemosensitivity Through APAF-1/Caspase-9 Apoptotic Pathway in Colorectal Cancer Cells[J]. Journal of Cellu- lar Biochemistry, 2014, 115(4):772-784.
  • 4Dong Q, Cai N, Tao T, et al. An Axis Involving SNAIl, microRNA- 128 and SP1 Modulates Glioma Progression[J]. PIoS one, 2014, 9(6):e98651.
  • 5Min J, Tao Z, Can L, et al. miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating celts[J]. Cancer Research, 2014, 74(15):4183-4195.
  • 6Donzelli S, Fontemaggi G, Fazi F, et al. MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function[J]. Cell Death & Differentiation, 2011, 19(6):1038-1048.
  • 7Ivanovska I, Ball A S, Diaz R L, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression[J]. Molecular and cellular biology, 2008, 28(7):2167-2174.
  • 8陈建武,王佩飞,郑佩赞,陈良英.结肠癌中COX-2表达及其与肿瘤脉管生成的关系[J].浙江医学,2012,34(20):1644-1646. 被引量:2
  • 9李楠,李夏雨,黄铄,沈守荣,王晓艳.miR-126靶向调控IRS1,SLC7A5及TOM1基因抑制结肠癌的增殖及侵袭转移[J].中南大学学报(医学版),2013,38(8):809-817. 被引量:9
  • 10张秦,张贺峰,曹琴英.microRNA-142-3p对TET2基因的调控及其对卵巢癌细胞SKOV3增殖的影响[J].现代妇产科进展,2016,25(10):721-725. 被引量:3

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部